Claim it free in under 5 minutes — verified by GSTIN, DigiLocker, or WhatsApp OTP. You control what buyers see, respond to inquiries, and post on RFQs.
Niihara International is a global pharmaceutical company focused on expanding access to proven therapies for patients with serious and underserved medical conditions. Founded by Dr. Yutaka Niihara, the company specializes in L-glutamine therapy for sickle cell disease, a genetic blood disorder causing chronic pain and life-threatening complications. Their mission is to reduce disease complications and improve quality of life through clinically validated treatments.
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Limited government data available — 4 criteria met
Government-registered export credentials verified from DGFT and MCA registries.
NIIHARA INTERNATIONAL PHARMA PRIVATE LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
Other verified manufacturers in the same network — discovered via MCA21 cross-references.